Sign inGet started

Gallagher Neil

Insider CIK 1972849 · SNDX President, Head of R&D · FHTX Director · ZYME Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
FHTX Foghorn Therapeutics Inc. A Award deriv2026-06-242026-06-2528,000$4.08 $114.2K28,000SEC↗
FHTX Foghorn Therapeutics Inc. A Award deriv2025-05-012025-05-0250,000$4.16 $208.0K50,000SEC↗
SNDX Syndax Pharmaceuticals Inc S Sale2025-02-102025-02-124,618$15.50 $71.6K85,095SEC↗
SNDX Syndax Pharmaceuticals Inc A Award deriv2025-02-052025-02-07110,500$14.65 $1.62M110,500SEC↗
SNDX Syndax Pharmaceuticals Inc A Award2025-02-052025-02-0718,500— $066,313SEC↗
SNDX Syndax Pharmaceuticals Inc A Award2025-02-052025-02-0723,400— $089,713SEC↗
ZYME Zymeworks Inc. A Award deriv2024-12-102024-12-1231,000— $031,000SEC↗
ZYME Zymeworks Inc. A Award deriv2024-04-022024-04-0274,000— $074,000SEC↗
SNDX Syndax Pharmaceuticals Inc A Award deriv2024-02-072024-02-0969,375$22.28 $1.55M69,375SEC↗
SNDX Syndax Pharmaceuticals Inc A Award2024-02-072024-02-0913,125— $047,813SEC↗
SNDX Syndax Pharmaceuticals Inc A Award2024-02-072024-02-0934,688— $034,688SEC↗
SNDX Syndax Pharmaceuticals Inc A Award deriv2023-04-102023-04-12250,000$19.35 $4.84M250,000SEC↗